by Clinical Neuropsychologist Online | Thursday, October 8, 2026 | Paediatric Neuropsychology
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | October 8, 2026 Neuro-Paediatric Previous Page
by Clinical Neuropsychologist Online | Thursday, October 8, 2026 | Neurorehabilitation
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | October 8, 2026 Neuro-Rehab Previous Page
by Clinical Neuropsychologist Online | Thursday, October 8, 2026 | Dementia
Dementia, Ahead of Print. To map the evidence of disparities in cognition across different social determinants of health (SDOH), examine how SDOH are measured in the context of research on cognitive outcomes and identify knowledge gaps. PubMed, the Cochrane Library,...
by Clinical Neuropsychologist Online | Thursday, October 8, 2026 | Neuroscience
Nature Neuroscience, Published online: 08 October 2026; doi:10.1038/s41593-026-02472-0Hou et al. show a drug target compendium supported by human genetic and real-world patient data for Alzheimer’s disease and validate epoxide hydrolase 2 as a causal Alzheimer’s...
by Clinical Neuropsychologist Online | Thursday, October 8, 2026 | Dementia
Abstract BACKGROUND Tau pathology in Alzheimer’s disease (AD) propagates along the brain’s connectome, yet the mechanisms by which tau drives neuronal dysfunction remain unclear. We hypothesized that dysfunction primarily emerges in regions close to...
